Accès ouvert
2026
article
OpenAlex
Barbara Tettenborn, Georgia Ramantani, Dominique Flügel, Verena Gaus et autres
Women with epilepsy (WWE) encounter distinct and evolving challenges across the lifespan that require clinical management extending beyond seizure control alone. Although awareness of sex-specific aspects of epilepsy has increased, important gaps remain in their integration into routine care. This review synthesizes …
Accès ouvert
2026
article
OpenAlex
Sophie Schlabitz, Jakob I. Doerrfuss, Jonas M. Hebel, Péter Körtvélyessy et autres
BACKGROUND: Neurofilament light chain (Nf-L) is an established biomarker for neuronal damage and a prognostic parameter in many diseases of the central nervous system (CNS). In epilepsy, most studies have focused on Nf-L levels either in epileptic seizures or in status epilepticus. …
de
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Barbara Tettenborn, Georgia Ramantani, Dominique Flügel, Verena Gaus et autres
Women with epilepsy (WWE) encounter distinct and evolving challenges across the lifespan that require clinical management extending beyond seizure control alone. Although awareness of sex-specific aspects of epilepsy has increased, important gaps remain in their integration into routine care. This review synthesizes …
Accès ouvert
2026
article
OpenAlex
Barbara Tettenborn, Georgia Ramantani, Dominique Flügel, Verena Gaus et autres
Women with epilepsy (WWE) encounter distinct and evolving challenges across the lifespan that require clinical management extending beyond seizure control alone. Although awareness of sex-specific aspects of epilepsy has increased, important gaps remain in their integration into routine care. This review synthesizes …
ch, de, it
(code pays fourni par la source)
2025
article
OpenAlex
Tameem Alhammoud, Verena Gaus, Bettina Schmitz
Accès ouvert
2025
article
OpenAlex
Alexander B. Kowski, Sophie Schlabitz, David Steinbart, Martin Holtkamp et autres
OBJECTIVE: In patients with epilepsy, adverse events (AE) of anti-seizure medication (ASM) may lead to unfavorable quality of life and non-adherence to treatment. This retrospective study aimed to identify risk factors for overall AE burden and specific AE in patients with dual …
de
(code pays fourni par la source)
2024
article
OpenAlex
Verena Gaus, M Feldmann, Bettina Schmitz
de
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Theresia Knoche, Leon Alexander Danyel, Lisa Varlet, Paula Haffner et autres
Idiopathic intracranial hypertension (IIH) has its highest prevalence among women of childbearing age and therefore frequently coincides with pregnancy. This retrospective cohort study aimed to explore the impact of pregnancy on the clinical course, ophthalmologic findings and on the therapeutic management of …
de
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Theresia Knoche, Leon Alexander Danyel, Lisa Varlet, Paula Haffner et autres
de
(code pays fourni par la source)
Accès ouvert
2023
erratum
OpenAlex
Dorothee Kübler, Melanie Astalosch, Verena Gaus, Patricia Krause et autres
Correction to: Neurological Sciences (2023)https://doi.org/10.1007/s10072-023-06598-yThe above article was published with error in author names. The correct capturing of the author name “Ana Luísa de Almeida Marcelino” has been updated.The Original article has been corrected.
de
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Theresia Knoche, Verena Gaus, Paula Haffner, Alexander B. Kowski
BACKGROUND: Neurofilament light chain (NfL) reflects axonal damage in neurological disorders. It has recently been evaluated in idiopathic intracranial hypertension (IIH). A biomarker indicating the severity of optic nerve damage in IIH could support diagnostic accuracy and therapeutic decisions. METHODS: We retrospectively …
de
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Dorothee Kübler, Melanie Astalosch, Verena Gaus, Patricia Krause et autres
INTRODUCTION AND GOAL: The investigation of gender differences in treatment response is crucial for effective personalized therapies. With only 30%, women are underrepresented in trials for deep brain stimulation (DBS) in Parkinson's disease (PD). It is therefore important to evaluate gender-specific outcomes …
de
(code pays fourni par la source)